Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BiShengZhiYan (BSZY) cream is a topical Traditional Chinese Medicine (TCM) formulation developed for the treatment of mild-to-moderate atopic facial dermatitis. It is a hospital-specific preparation from the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, affiliated with the Shanghai University of Traditional Chinese Medicine. The cream is designed to reconstruct the damaged skin barrier and strengthen the skin's inherent repair capacity. Clinical investigations, including a randomized, double-blind, controlled trial (NCT05792826), evaluate its efficacy using the Scoring Atopic Dermatitis (SCORAD) scale and other safety indicators to provide evidence for its use in delicate facial skin conditions where standard options may be limited.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BiShengZhiYan cream.